Ratio Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2021-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://ratiotx.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Early Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Early Phase 1
1 (100.0%)Exploratory PK and Imaging Study of PSMA-Targeted Trillium Compounds and PTI-122 in Metastatic Prostate Cancer
Early Phase 1
Completed
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2023-03-17
- Last Posted Date
- 2023-12-13
- Lead Sponsor
- Ratio Therapeutics, Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT05773703
- Locations
- 🇺🇸
Biogenix Molecular, Miami, Florida, United States
🇺🇸Advanced Molecular Imaging & Therapy, Glen Burnie, Maryland, United States
🇺🇸XCancer Omaha/Urology Cancer Center, Omaha, Nebraska, United States
News
No news found